Caxton Associates (New York)’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,737
| Closed | -$201K | – | 396 |
|
|
2023
Q2 | $201K | Sell |
7,737
-1,416
| -15% | -$36.8K | 0.03% | 414 |
|
|
2023
Q1 | $263K | Sell |
9,153
-12,258
| -57% | -$352K | 0.04% | 371 |
|
|
2022
Q4 | $634K | Sell |
21,411
-22,393
| -51% | -$663K | 0.04% | 180 |
|
|
2022
Q3 | $1.04M | Buy |
43,804
+16,537
| +61% | +$394K | 0.14% | 88 |
|
|
2022
Q2 | $609K | Buy |
+27,267
| New | +$609K | 0.06% | 211 |
|